FDA Adverse Event Summary report: N

EZ BREATHE ATOMIZER

MDR report key: 3170013 · Received June 7, 2013

Report

Report Number
3005442893-2013-00026
Date Received
June 7, 2013
Date of Event
April 23, 2013
Report Date
May 7, 2013
Manufacturer
HEALTH & LIFE (SUZHOU) CO., LTD.
Product Code
CCQ
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AN EVAL OF THIS FAILURE MODE FROM THE DESIGN FAILURE MODES AND EFFECTS ANALYSIS OF THIS PRODUCT, THAT THE USE OF THE PRODUCT IN A MANNER LIKELY TO CAUSE ADVERSE HEALTH CONSEQUENCE IS IMPROBABLE AND THAT NO COMPLAINTS DOCUMENTING DEATHS OR SERIOUS INJURIES HAVE BEEN REC'D. HERE WITH THE INVESTIGATION REPORT AS ATTACHMENT, AND THE COMPLAINED DEVICE WAS NOT AVAILABLE FOR FURTHER INVESTIGATION, THEREFORE, THE ROOT CAUSE CANNOT BE IDENTIFIED.

Description of Event or Problem · 1

THE CUSTOMER CONTACTED NEPHRON PHARMACEUTICALS CORPORATION REGARDING AN ADVERSE DRUG EXPERIENCE AND PRODUCT COMPLAINT ON (B)(6) 2013. THE PT REPORTED THAT SHE EXPERIENCED JITTERINESS AND HEADACHES DURING THE INITIAL USE OF ASTHMANEFRIN INHALATION SOLUTION VIA THE EZ BREATHE ATOMIZER; HOWEVER, SHE REPORTED THAT HER BREATHING IMPROVED. AFTER THREE USES OF THE PRODUCT, THE CUSTOMER REPORTED THAT THE ATOMIZER WOULD ONLY PRODUCE A SMALL AMOUNT OF AEROSOL. SHE TOOK THE ASTHMANEFRIN AND EZ BREATH ATOMIZER TO HER JOB SINCE SHE WAS HAVING TROUBLE BREATHING. SHE REPORTED THAT THE ATOMIZER WOULD ONLY PRODUCE A SMALL AMOUNT OF MIST, AND THE MIST WAS INSUFFICIENT TO ALLEVIATE HER ASTHMA SYMPTOMS. AS A RESULT OF THE DEVICE'S PERFORMANCE, THE CUSTOMER REPORTED THAT SHE SUFFERED ASTHMA PROBLEMS FROM TUESDAY EVENING UNTIL WEDNESDAY MORNING. AT AROUND 6AM ON WEDNESDAY MORNING, THE CUSTOMER REPORTED THAT SHE WENT TO THE HOSPITAL FOR TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
253558 EZ BREATHE ATOMIZER ATOMIZER CCQ HEALTH & LIFE (SUZHOU) CO., LTD. EZ-100 UNIDENTIFIED

Patients

Seq Age Sex Outcome Treatment
1 44 YR Hospitalization| O ASTHMANEFRIN INHALATION SOLUTION